WallStreetZenWallStreetZen

NASDAQ: DMRA
Damora Therapeutics Inc Stock Ownership - Who owns Damora Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Damora Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Lori FirmaniChief Financial Officer2026-01-02135$21.41
$2.89kSell
Hans T. SchambyeChief Executive Officer2026-01-02700$21.38
$14.97kSell
Garrett WinslowGeneral Counsel2026-01-02255$21.38
$5.45kSell
Lori FirmaniInterim CFO2025-07-03147$3.39
$498.33Sell
Hans T. SchambyeChief Executive Officer2025-07-03735$3.38
$2.48kSell
Garrett WinslowGeneral Counsel2025-07-03260$3.39
$881.40Sell

1 of 1

DMRA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DMRA insiders and whales buy or sell their stock.

DMRA Shareholders

What type of owners hold Damora Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fairmount Funds Management LLC14.16%8,713,000$214.34MInsider
Orbimed Advisors LLC4.13%2,542,186$62.54MInsider
Holdings A. Novo4.06%2,497,791$61.45MInsider
Chau Quang Khuong1.68%1,031,811$25.38MInsider
Stephan Christgau0.89%546,136$13.43MInsider
Jennifer Jarrett0.81%500,000$12.30MInsider
L. Becker Hewes0.43%264,629$6.51MInsider
Vanguard Capital Management LLC0.33%201,847$4.97MInstitution
Sherwin Sattarzadeh0.31%190,376$4.68MInsider
Ubs Group Ag0.26%160,415$3.95MInstitution

1 of 3

DMRA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DMRA0.91%26.80%Net Selling
NUVB8.12%45.70%Net BuyingNet Buying
GLUE9.92%90.08%Net SellingNet Selling
NVAX31.41%17.12%Net SellingNet Selling
ARDX13.43%86.57%Net BuyingNet Buying
View Top Biotech Stocks

Damora Therapeutics Stock Ownership FAQ

Who owns Damora Therapeutics?

Damora Therapeutics (NASDAQ: DMRA) is owned by 0.91% institutional shareholders, 26.80% Damora Therapeutics insiders, and 72.29% retail investors. Fairmount Funds Management LLC is the largest individual Damora Therapeutics shareholder, owning 8.71M shares representing 14.16% of the company. Fairmount Funds Management LLC's Damora Therapeutics shares are currently valued at $214.34M.

If you're new to stock investing, here's how to buy Damora Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.